No Detail Found!

Association of Serum Sparc with Insulin Resistance in Type-2 Diabetes Mellitus.

Author(s)
Komal Nadeem Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Umbreen Ahmed Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Shahid Ahmed Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Hina Arif Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Abstract
Objective: To determine the association of serum SPARC with insulin resistance in type-2 diabetes. Study Design: Descriptive study. Place and Duration of Study: Physiology department and CREAM lab, Army medical college, Rawalpindi, in collaboration with Military Hospital Rawalpindi, from Feb 2016 to Oct 2016. Material and Methods: Sixty individuals were recruited in this descriptive study. Thirty diagnosed cases of type2 DM were included, while thirty age and gender matched healthy individuals were included as controls through non-probability purposive sampling. Controls were labelled as group A, while cases were labelled as group B. Patients with type-1 DM, type-2 DM on insulin therapy, hyperglycemic states other than DM and inflammatory disorders were excluded from the study. Data were collected after informed and written consent. Blood samples were withdrawn under strict aseptic measures and serum was stored at -20oC. Serum insulin levels and serum SPARC levels were analyzed by enzyme linked immunosorbent assay (ELISA). Insulin resistance was determined using homeostasis model assessment of insulin resistance (HOMA-IR), and its value >1.5 was considered significant. Results: Fasting insulin levels were significantly higher in group B as compared with group A, supporting the diagnosis of type-2 DM. HOMA-IR values were greater than 1.5 in group B, thus establishing significant insulin resistance. Serum SPARC levels were significantly higher in group B than group A (17.7 ± 1.14 vs 8.7 ± 1.08 ng/ml) with p-value<0.001. Serum SPARC levels showed positive correlation with fasting insulin levels and HOMA-IR values. Conclusion: Our study showed a positive correlation between serum SPARC levels and insulin resistance, which indicates that SPARC plays an important role in the development of insulin resistance in type-2 diabetes mellitus.
Publication Details
Page(s) 757-761
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 67, Issue: 5, Year: 2017

Request the full text from PASTIC

References
KharroubiAT,DarwishHM,,2015,Diabetes mellitus: The epidemic of the century,World J Diabetes,6,850,67
SiddiquiFJ,AvanBI,MahmudS,NananDJ,JabbarA,AssamPN,,2015,Uncontrolled diabetes mellitus: Prevalence and risk factors among people with type 2 diabetes mellitus in an Urban District of Karachi, Pakistan,Diabetes Res Clin Pract,107,148,56
DownsCA,FaulknerMS,,2015,Toxic stress, inflammation and symptomatology of chronic complications in diabetes,World J Diabetes,6,554,65
HameedI,MasoodiSR,MirSA,NabiM,GhazanfarK,GanaiBA,,2015,Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition,World J Diabetes,6,598,612
KosK,WildingJP,,2010,SPARC: A key player in the pathologies associated with obesity and diabetes,Nat Rev Endocrinol,6,225,35
BradshawAD,,2012,Diverse biological functions of the SPARC family of proteins,Int J Biochem Cell Biol,44,480,8
NagarajuGP,DontulaR,El-RayesBF,LakkaSS,,2014,Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis,J Carcinog Mutagen,35,967,73
YanQ,SageEH,,1999,SPARC, a Matricellular Glycoprotein with Important Biological Functions,Journal of Histochemistry & Cytochemistry,47,1495,505
NagarajuGP,SharmaD,,2011,Anti-cancer role of SPARC, an inhibitor of adipogenesis,Cancer Treat Rev,37,559,66
NieJ,SageEH,,2009,SPARC functions as an inhibitor of adipogenesis,J Cell Commun Signal,3,247,54
LeeSH,LeeJA,ParkHS,SongYS,JangYJ,KimJH,,2013,Associations among SPARC mRNA expression in adipose tissue, serum SPARC concentration and metabolic parameters in Korean women,Obesity,21,2296,302
KosK,WongS,TanB,GummessonA,JernasM,FranckN,,2009,Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose,Diabetes,58,1780,8
SinghY,GargMK,TandonN,MarwahaRK,,2013,A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents,J Clin Res Pediatr Endocrinol,5,245,51
ShenY,ZhaoY,YuanL,YiW,ZhaoR,YiQ,,2014,SPARC is over-expressed in adipose tissues of diet-induced obese rats and causes insulin resistance in 3T3-L1 adipocytes,Acta Histochem,116,158,66
0

Citations

0

Downloads

104

Views